SCHEMBL10076298

SCHEMBL10076298

CCc1cc(CC)cc(NC(=O)C2CCCNC2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.54
ALOX15 P16050 1/20 0.51
ULK1 O75385 1/20 0.50
F10 P00742 1/20 0.49
KHK P50053 1/20 0.46
LMNA P02545 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
AURKA O14965 1/20 0.44
AURKB Q96GD4 1/20 0.44
TNKS O95271 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
ROCK2 O75116 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SLC6A1 P30531 2/20 0.41
SLC6A11 P48066 1/20 0.41
TSHR P16473 1/20 0.41
SLC6A13 Q9NSD5 1/20 0.41
WNT1 P04628 2/20 0.41
GSK3B P49841 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10076207 0.87 SMN1; SMN2 (0.74) SMN1; SMN2ALOX15ULK1F10KHK
SCHEMBL13766314 0.81 KMT2A (0.55) SMN1; SMN2ALOX15KHKLMNANPSR1
SCHEMBL19408118 0.79 MEN1 (0.69) SMN1; SMN2ALOX15ULK1F10LMNA
SCHEMBL18073044 0.77 F10 (0.59) SMN1; SMN2ALOX15ULK1F10KHK
SCHEMBL2448229 0.76 ULK1 (0.56) ALOX15ULK1KHKLMNANPSR1
SCHEMBL2446479 0.76 HPGD (0.66) SMN1; SMN2ALOX15ULK1F10KHK
SCHEMBL1318173 0.76 HPGD (0.66) SMN1; SMN2ALOX15ULK1F10KHK
SCHEMBL1318166 0.76 HPGD (0.66) SMN1; SMN2ALOX15ULK1F10KHK
SCHEMBL26553739 0.75 SPHK1 (0.60) SMN1; SMN2ALOX15ULK1F10RAB9A
SCHEMBL259381 0.75 NPSR1 (0.72) SMN1; SMN2ALOX15ULK1F10KHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093231-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2012-01-10 US disclosed
US-8093231-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2012-01-10 US disclosed
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES TELIK, INC. 2008-02-14 US disclosed
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES TELIK, INC. 2008-02-14 US disclosed
US-7262182-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2007-08-28 US disclosed
US-7262182-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2007-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES MTAP, TYMP, PHOSPHO1 SMN1; SMN2 1097/4885ALOX15 4654/4885ULK1 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.